Advertisement
Screener

Outset Medical, Inc. (OM) EBITDA

Outset Medical, Inc. (OM) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$15.05M*; Operating income -$15.68M; Depreciation and amortization $627.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$16.12M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$16.75M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$14.80M*; Operating income -$15.81M; Depreciation and amortization $1.01M*.

Complete source-backed ebitda history.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$15.05M*-$15.68M$627.00K*$31.64M-47.57%*$111.00K*-$9.63M*$18.35M$5.45M(m)$220.00K
2026-03-31Reported-$16.12M(m)(m)(m)-57.87%$65.00K-$12.84M$15.77M$5.62M(m)$217.00K
2025-12-31Reported-$16.75M(m)(m)(m)-58.00%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$14.80M*-$15.81M$1.01M*$29.43M-50.29%*$160.00K*-$6.32M*$17.84M$5.38M(m)$404.00K
2025-06-30Reported-$15.71M*-$16.86M$1.16M*$31.42M-50.00%*$292.00K*-$4.82M*$19.55M$5.29M(m)$104.00K
2025-03-31Reported-$15.11M(m)(m)(m)-50.77%$123.00K-$25.66M$18.69M$5.51M(m)$115.00K
2024-12-31Reported-$20.45M(m)(m)(m)-69.41%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$22.45M*-$23.84M$1.39M*$28.67M-78.31%*$395.00K*-$20.57M*$18.85M$8.14M(m)$182.00K
2024-06-30Reported-$29.29M*-$30.76M$1.47M*$27.39M-106.96%*$120.00K*-$33.34M*$17.61M$9.73M(m)$151.00K
2024-03-31Reported-$35.45M(m)(m)(m)-125.86%$354.00K-$45.91M$19.95M$12.63M(m)$162.00K
2023-12-31Reported-$35.91M(m)(m)(m)-117.70%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$43.99M*-$45.45M$1.47M*$30.36M-144.88%*$782.00K*-$34.00M*$23.20M$16.08M(m)$86.00K
2023-06-30Reported-$41.96M*-$43.48M$1.51M*$36.04M-116.44%*$795.00K*-$28.18M*$28.34M$14.91M(m)$133.00K
2023-03-31Reported-$42.1M(m)(m)(m)-125.80%$810.00K-$44.76M$27.04M$13.79M(m)$192.00K
2022-12-31Reported-$38.56M(m)(m)(m)-120.46%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$39.69M*-$41.00M$1.31M*$27.76M-142.95%*$2.74M*-$34.31M*$23.43M$13.06M(m)$20.00K
2022-06-30Reported-$42.40M*-$43.72M$1.32M*$25.06M-169.20%*$2.00M*-$38.58M*$21.27M$13.52M(m)$96.00K
2022-03-31Reported-$35.21M(m)(m)(m)-115.26%$1.48M-$38.34M$26.11M$10.83M(m)$115.00K
2021-12-31Reported-$39.5M(m)(m)(m)-140.32%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$28.82M*-$30.14M$1.31M*$26.32M-109.53%*$491.00K*-$28.13M*$23.37M$9.73M(m)$0.00
2021-06-30Reported-$28.60M*-$29.91M$1.31M*$25.22M-113.42%*$847.00K*-$30.84M*$24.16M$8.03M(m)$35.00K
2021-03-31Reported-$28.43M(m)(m)(m)-124.06%$919.00K-$38.62M$22.63M$7.57M(m)$39.00K
2020-12-31Reported-$29.69M(m)(m)(m)-172.12%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$40.19M*-$40.73M$541.00K*$13.76M-292.18%*$1.46M*-$29.12M*$18.88M$9.18M(m)(m)
2020-06-30Reported-$24.53M*-$24.91M$383.00K*$11.74M-208.87%*$2.19M*-$19.17M*$16.51M$6.05M(m)(m)
2020-03-31Reported-$19.91M(m)(m)(m)-276.84%$2.80M-$24.89M$10.75M$5.84M(m)$0.00
2019-09-30Reported(m)-$18.45M(m)$2.63M(m)(m)(m)$7.92M$5.71M(m)$20.00K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$62.37M(m)(m)(m)-52.20%$798.00K-$46.33M$72.72M$21.23M(m)$718.00K
2024-12-31Reported-$107.65M(m)(m)(m)-94.69%$912.00K-$116.30M$75.13M$38.40M(m)$491.00K
2023-12-31Reported-$163.96M(m)(m)(m)-125.76%$3.44M-$131.37M$101.38M$57.31M(m)$523.00K
2022-12-31Reported-$155.85M(m)(m)(m)-135.08%$8.32M-$145.73M$97.54M$48.85M(m)$295.00K
2021-12-31Reported-$125.36M(m)(m)(m)-122.18%$3.11M-$130.26M$94.99M$36.74M(m)$199.00K
2020-12-31Reported-$114.31M(m)(m)(m)-228.91%$9.08M-$99.02M$62.97M$28.85M(m)$0.00
2019-12-31Reported-$68.82M(m)(m)(m)-456.45%$3.29M-$70.29M$32.88M$23.33M(m)$20.00K
2018-12-31Reported-$45.49M(m)(m)(m)-2266.77%$1.77M-$46.44M$8.12M$22.92M(m)$25.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Vivani Medical, Inc. (VANI)United States$0.111B
Nuwellis, Inc. (NUWE)United States$0.003B